Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
l�ll
Carvedilol in the treatment of portal hypertension Al-Ghamdi HSaudi J Gastroenterol 2011[Mar]; 17 (2): 155-8Variceal bleeding is a major event in the natural history of end-stage liver disease with a subsequent high mortality rate. Non-selective beta-blockers are currently the drugs of choice for preventing first variceal bleeding. Endoscopic rubber band ligation of high risk varices features as a first line option if cirrhotic patients cannot tolerate beta-blockers. Despite adequate beta-blockade, some patients may still present with variceal bleeding. The effect of carvedilol, a non-selective beta and alpha-1 receptor-blocker, on lowering portal pressure has been investigated in several clinical trials and found to be superior to propranolol in both acute and chronic hemodynamic studies. Recently, carvedilol has also been compared with band ligation for primary prophylaxis against variceal bleeding with equivalent results to band ligation. Patient tolerance to carvedilol in advanced liver disease remains a source of concern. This review examines the place of carvedilol as an alternative to the currently recommended pharmacological therapy in prophylaxis against variceal bleeding.|Antihypertensive Agents/*therapeutic use[MESH]|Carbazoles/*therapeutic use[MESH]|Carvedilol[MESH]|Gastrointestinal Hemorrhage/etiology/prevention & control[MESH]|Humans[MESH]|Hypertension, Portal/complications/*drug therapy[MESH]|Propanolamines/*therapeutic use[MESH] |